Speaker illustration

Professor Steven E Nissen

Cleveland Clinic Hospital, Cleveland (United States of America)

Member of:

European Society of Cardiology

Steven E. Nissen MD is Chairman of the Chief Academic Officer of the Heart and Vascular Institute at the Cleveland Clinic and Professor of Medicine at the Lerner College of Medicine. In 2006-2007 he served as President of the American College of Cardiology. Contributions to scientific literature include >600 journal articles. Dr. Nissen manages C5R Research, an organization at the Cleveland Clinic that partners with industry in conducting clinical trials. He specializes in lipid-metabolic, diabetes and obesity trials, but has directed trials as study chair for clinical trials in multiple areas of cardiovascular medicine. He does not accept honoraria or other compensation from industry to stay completely independent. In 2007, Time Magazine selected Dr. Nissen as one of the world’s 100 most influential people. Beginning in 2015, he was named by Thompson-Reuters as one of the world’s most highly cited physician-scientists.

Risk factors - Obesity

Event: ESC Congress 2022

Topic: Obesity

Session type: Moderated ePosters

Thumbnail

Diabetes and the Heart 3

Event: ESC Congress 2022

Topic: Diabetes and the Heart

Session type: Moderated ePosters

Thumbnail

New insights for acute coronary syndrome pharmacotherapy

Event: ESC Congress 2019

Topic: Treatment

Session type: Rapid Fire Abstracts

Thumbnail

Cardiovascular risk reduction and dyslipidaemia management: current state and future therapies

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session type: Satellite Symposium

Thumbnail

Prevention 360: Strategies for Managing Cardiovascular Risk

Event: ESC Congress 2016

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: Satellite Symposium

Thumbnail

Current and future therapeutic options targeting residual Cardiovascular Disease (CVD) risk: emerging therapies for the treatment of dyslipidemia

Event: ESC Congress 2015

Topic: Lipids

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb